Business Context and Reporting Period
This Form 6-K filing by Immunocore Holdings Plc, dated April 18, 2023, serves as a notice of the Company's Annual General Meeting (AGM) scheduled for May 16, 2023. The filing distributes the notice of the AGM, proxy forms, and the UK Annual Report and accounts for the year ended December 31, 2022, to ordinary shareholders and American Depositary Share (ADS) holders.
Key Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced UK Annual Report for the year ended December 31, 2022, which is posted on the Company's investor relations website but not detailed in this specific Form 6-K document.
Material Changes
No material financial changes or operational updates are disclosed in this filing. The document is procedural, focusing on the distribution of governance materials and voting instructions for the upcoming AGM.
Guidance, Outlook, and Risks
This filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It references the UK Annual Report for comprehensive information regarding the Company's performance and risks.
Investor Verification Checklist
- Verify the date, time, and location of the Annual General Meeting (May 16, 2023, at 2:00 p.m. BST).
- Confirm the record date for ADS holders (April 10, 2023) to ensure voting eligibility.
- Access the UK Annual Report for the year ended December 31, 2022, on the Company's website for detailed financial statements.
- Review the voting instruction cards provided by Citibank, N.A., for ADS holders.